Furthermore, our analysis of the PRC2 interactome revealed that 9 out of 15 genes in this gene set were significantly dysregulated in AML-ASXL1, while none reached significance in the BOS samples [54, 55]. The gene discussed is ASXL1; the disease is acute myeloid leukemia.